Nicholas A. Butowski

MD

Neuro-oncologist
Avid football – also known as soccer – fan

Dr. Nicholas Butowski is a neuro-oncologist who specializes in brain tumors, neuroimaging, cognitive and rehabilitative neurology, and complementary therapies for neurological disorders. He is director of clinical services in neuro-oncology and a researcher at the Brain Tumor Center.

In his research, Butowski focuses on developing treatments for primary brain tumors as well as methods to ensure good quality of life for patients and to assist them in recovering from or coping with brain injury.

Butowski earned his medical degree at the University of Illinois at Chicago. He completed a residency in neurology and a fellowship in neuro-oncology at UCSF. He is a member of the American Academy of Neurology, American Society of Clinical Oncology and Society for Neuro-oncology.

  • Education

    University of Illinois College of Medicine, 1999

  • Residencies

    UCSF Medical Center, Neurology, 2003

  • Fellowships

    UCSF Medical Center, Neuro-oncology, 2004

  • Academic Title

    Professor

Compassion is not a virtue; it is a commitment.

Conditions I specialize in

Where I see patients (1)

    My reviews

    4.9

    Overall Experience
    131 Ratings
    About our process
    Feb 17, 2023
    Dr. B is always very helpful in explaining my test results and listening and answering any questions or issues I may have.
    Jan 22, 2023
    Good
    Jan 13, 2023
    A post appointment email follow up was a nice touch.
    Jan 02, 2023
    Always a pleasure and very much appreciate the time invested in my health.
    Dec 30, 2022
    It was a good meeting with Dr. Butowski about my MRI results. He didn't show the results of my MRI scan this time like he usually does before but I trust him as he confirmed it's stable so I suppose it's not necessary to see them if they are the same as before.
    Dec 29, 2022
    Dr. Butowski is an excellent provider. Decent human being; extremely knowledgeable; compassionate. Top notch communication. If only he was chair of this department.
    Dec 21, 2022
    Excellent service
    Dec 10, 2022
    Doctor butowski was great. Heard our concerns and made surgery happen while we sat with him.
    Nov 28, 2022
    Great discussion of why optune does not work
    Nov 11, 2022
    Excellent care!
    Oct 29, 2022
    Very good service and experience
    Aug 18, 2022
    Deal with 6 different hospital staffs and without comparison the easiest and friendliest staff I encounter. Made it a point to complete this time to show appreciation I might not show during visit.
    Aug 12, 2022
    Dr. Butowski is literally the BEST.
    Aug 11, 2022
    Nick is good guy
    Aug 04, 2022
    Dr Butowski gives excellent advice.
    Jul 30, 2022
    Dr. Butowski is always very open and kind to my needs and asks if I have any questions and he is caring to respond.
    Apr 20, 2022
    Best doctor anywhere of any kind.
    Apr 16, 2022
    Always excellent top notch care by this provider
    Mar 30, 2022
    Dr. Butowski is amazing. He is always attentive and provides excellent care and support. He is an asset to the UCSF care system.
    Jan 05, 2022
    Doctor was personable and knowledgeable
    Nov 02, 2021
    Dr. Butowski really should teach a class to other doctors on bedside manner:) Such a gem:) I am SO grateful to be in his care:)
    Jul 30, 2021
    Excellent experience!
    May 27, 2021
    Dr. Butowski is excellent. UCSF would really be losing a top-notch provider if he accepts a position elsewhere. Administration would be smart to proactively work to keep him.

    Selected research

    Decorative Caduceus

    A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

    Overall survival is defined from the time of randomization to death from any cause. Patients still alive at the time of an analysis will be considered censored at their date of last contact.

    Recruiting

    Decorative Caduceus

    RMC-5552 Monotherapy in Adult Subjects With Recurrent Glioblastoma

    MTD is defined as the maximal dose at which fewer than one-third of participants experience a dose-limiting toxicity (DLT).

    Recruiting

    Decorative Caduceus

    A Study of Berubicin in Adult Subjects With Recurrent Glioblastoma Multiforme

    To assess the effect of berubicin compared with lomustine on overall survival (OS) in adult patients with GBM that has recurred or progressed after standard initial therapy

    Recruiting

    Decorative Caduceus

    A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Pati...

    Recruiting

    Decorative Caduceus

    SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)

    To compare overall survival (OS) in patients with newly diagnosed glioblastoma between treatment arms A & B

    Recruiting

    Decorative Caduceus

    A Phase 1-2 Study of ST101 in Patients With Advanced Solid Tumors

    Number of Participants with a Dose-Limiting Toxicity (DLT)

    Recruiting

    Contact me

    Providers on my team

    Share